Women can and do have bleeding disorders. Despite long-standing misconceptions about bleeding disorders in women, women’s voices and experiences are now being taken more seriously. Symptoms of bleeding disorders in womenYou may have a…
Revisions: 244; 186; 173; 196
von Willebrand disease (VWD) is the most common inherited bleeding disorder and affects males and females equally in up to 1% of the general population. (1,2) VWD is associated with mucous membrane bleeding,…
*/
RespectWe uphold the dignity, identity, and lived experiences of every individual we work with and serve.AccountabilityWe take ownership of our actions, manage our responsibilities with integrity, and follow through on our commitments. …
What is von Willebrand Disease?Von Willebrand disease (VWD) is an inheritable bleeding disorder. Many different proteins are needed to make a person’s blood clot successfully. People with VWD are either missing or low in the clotting protein von…
Treatment Options for Bleeding DisordersThere are many different types of therapies to treat bleeding disorders, and new ones are in development. Each person may respond to a treatment in their own way, so it is important to work closely with your…
What Is Hemophilia A?Hemophilia A, also called factor VIII (8) deficiency or classic hemophilia, is a genetic disorder caused by missing or defective factor VIII (FVIII), a clotting protein. Although it is passed down from parents to children, about…
Revisions: 264, 245, 197, 185, 172.BackgroundInherited bleeding disorders are under-recognized as a cause of excessive uterine bleeding since uterine bleeding is expected during menstruation and with pregnancy.…
Objective:
To assess the dental experiences of patients with von Willebrand disease for the purpose of developing guidelines for screening and dental management.
Methods:
A…
Background:
Many hemophilia treatment centers (HTCs) have a comprehensive care clinic in which a variety of providers see patients with bleeding disorders. Registered dental hygienists (RDHs) are, in some cases,…
Revisions: 255; 258
A. Introduction
Emicizumab is a recombinant, humanized, bispecific immunoglobulin G4 monoclonal antibody that substitutes for part of the cofactor function of activated factor VIII (FVIIIa) by bridging activated…